These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1493844)

  • 21. Regional and systemic hemodynamic and humoral effects of transdermal nitroglycerin in mild hypertension.
    Pedrinelli R; Graziadei L; Panarace G; Duranti P; Motolese M; Salvetti A
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):636-41. PubMed ID: 2478778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical exercise increases plasma concentrations of nicotine during treatment with a nicotine patch.
    Klemsdal TO; Gjesdal K; Zahlsen K
    Br J Clin Pharmacol; 1995 Jun; 39(6):677-9. PubMed ID: 7654487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of gastroprotection by transdermal nitroglycerin in the rat.
    Calatayud S; Sanz MJ; Canet A; Bello R; de Rojas FD; Esplugues JV
    Br J Pharmacol; 1999 Jul; 127(5):1111-8. PubMed ID: 10455256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients.
    Vaillant L; Biette S; Machet L; Constans T; Monpère C
    Contact Dermatitis; 1990 Sep; 23(3):142-5. PubMed ID: 2126502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycerol trinitrate (nitroglycerin) plasma concentrations achieved after application of transdermal therapeutic systems to healthy volunteers.
    Gerardin A; Gaudry D; Moppert J; Theobald W; Fankhauser P
    Arzneimittelforschung; 1985; 35(2):530-2. PubMed ID: 3922382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamics and serum nitroglycerin concentration during intraoperative use of nitroglycerin patches].
    Saitoh K; Ishii R; Shimizu R; Harigai H
    Masui; 1992 Dec; 41(12):1889-93. PubMed ID: 1479656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cutaneous vasoconstrictor response in lower extremities during whole-body and local skin cooling in young women with a cold constitution.
    Yamazaki F
    J Physiol Sci; 2015 Sep; 65(5):397-405. PubMed ID: 25850923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal nitroglycerin: clinical and pharmacokinetic consequences of renewing the patch and the application site.
    Klemsdal TO; Mundal HH; Bredesen JE; Gjesdal K
    Eur J Clin Pharmacol; 1997; 52(5):379-81. PubMed ID: 9272407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB; Daxini BV; Noyce D; Kelly DT
    J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transcutaneous transport of trinitrin in children after application of nitroglycerin patches].
    Vaksmann G; Rey E; Francart C; Olive G; Dupuis C
    Presse Med; 1990 Dec; 19(42):1937-8. PubMed ID: 2147754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct effects of blood flow and temperature on cutaneous microvascular adaptation.
    Carter HH; Spence AL; Atkinson CL; Pugh CJ; Cable NT; Thijssen DH; Naylor LH; Green DJ
    Med Sci Sports Exerc; 2014 Nov; 46(11):2113-21. PubMed ID: 25338190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation Group.
    Clin Ther; 1991; 13(5):545-9. PubMed ID: 1799911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patch.
    Santoro A; Rovati LC; Setnikar I; Caplain H; Gualano V
    Arzneimittelforschung; 2000 Sep; 50(9):779-85. PubMed ID: 11050693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of transdermal nitroglycerin in children with congestive heart failure: a Doppler echocardiographic study.
    Vaksmann G; Pariente-Khayat A; Godart F; Francart C; Rey E; D'Athis P; Pons G; Rey C
    Pediatr Cardiol; 2001; 22(1):11-3. PubMed ID: 11123120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical non-iontophoretic application of acetylcholine and nitroglycerin via a translucent patch: a new means for assessing microvascular reactivity.
    Schonberger RB; Worden WS; Shahmohammadi K; Menn K; Silverman TJ; Stout RG; Shelley KH; Silverman DG
    Yale J Biol Med; 2006 Mar; 79(1):1-7. PubMed ID: 17876370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.